ATRA
Atara Biotherapeutics Inc
NASDAQ: ATRA · HEALTHCARE · BIOTECHNOLOGY
$4.77
+3.70% today
Updated 2026-04-30
Market cap
$40.97M
P/E ratio
1.95
P/S ratio
0.34x
EPS (TTM)
$2.57
Dividend yield
—
52W range
$4 – $19
Volume
0.3M
Atara Biotherapeutics Inc (ATRA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
5 of 8
Last 8 quarters
Avg EPS surprise
+36.8%
Last 4 quarters
Revenue YoY growth
-95.1%
Most recent quarter
EPS YoY growth
+70.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-4.1%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-14.8%
2026-03-17
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-17 | $-0.35 | -483.3% | $5.87 | $5.00 | -14.8% |
| 2025-11-12 | $-0.32 | -23.1% | $12.56 | $13.39 | +6.6% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-0.06 | $-0.35 | -483.3% | $1.59M | -95.1% |
| 2025-09-30 | $-0.26 | $-0.32 | -23.1% | $3.45M | -91.4% |
| 2025-06-30 | $-0.27 | $0.19 | +170.4% | $17.57M | -38.6% |
| 2025-03-31 | $-1.93 | $3.50 | +281.8% | $98.15M | +258.8% |
| 2024-12-31 | $-3.49 | $-1.19 | +65.9% | $32.75M | +670.3% |
| 2024-09-30 | $-17.27 | $-2.93 | +83.0% | $40.19M | +1779.8% |
| 2024-06-30 | $-1.56 | $-3.10 | -98.7% | $28.64M | +2892.7% |
| 2024-03-31 | $-0.26 | $-0.23 | +11.5% | $27.36M | +2131.4% |
| 2023-12-31 | $-0.48 | $-0.56 | -16.7% | $4.25M | — |
| 2023-09-30 | $-0.66 | $-0.66 | +0.0% | $2.14M | — |
| 2023-06-30 | $-0.67 | $-0.68 | -1.5% | $957000.00 | — |
| 2023-03-31 | $-0.39 | $-0.72 | -84.6% | $1.23M | — |
Frequently asked questions
Has Atara Biotherapeutics Inc beaten earnings estimates?
Atara Biotherapeutics Inc has beaten Wall Street EPS estimates in 5 of its last 8 quarterly reports, with an average EPS surprise of +36.8% over the last 4 quarters.
How does ATRA stock react to earnings?
ATRA stock has moved an average of -4.1% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Atara Biotherapeutics Inc's revenue growth rate?
Atara Biotherapeutics Inc reported year-over-year revenue growth of -95.1% in its most recent quarter, with EPS growing +70.6% year-over-year.